PMC:7600245 / 21186-21373
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T96 | 25-30 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T197 | 25-30 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T155 | 61-142 | Sentence | denotes | It also decreases the potential renal toxicity of the monophosphate intermediate. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 568 | 115-128 | Chemical | denotes | monophosphate | |
| 569 | 143-164 | Chemical | denotes | Tenofovir alafenamide | MESH:C442442 |
| 581 | 16-24 | Disease | denotes | infected | MESH:D007239 |
| 582 | 93-107 | Disease | denotes | renal toxicity | MESH:D007674 |